🔬 Pharmidex at "From Innovation to Adoption in Gene Therapies"! 🚀
February 27, 2025

We’re excited to announce that Radhakrishnan Venkatasamy, our Principal Research Scientist specializing in autoimmune diseases, will be attending From Innovation to Adoption in Gene Therapies, hosted by One Nucleus on Thursday, 27 February 2025 at Level 39, Canary Wharf, London.


This event brings together experts to explore the latest advancements in gene therapies, and Radhakrishnan is eager to connect with fellow innovators to discuss new opportunities for collaboration. 

Let’s work together to accelerate drug discovery and development!


📍 Event details:

📅 Date: Thursday, 27 February 2025

⏰ Time: 15:00 – 19:30

📍 Location: Level 39, One Canada Square, Canary Wharf, London E14 5AB

🔗 More info: (https://lnkd.in/efEUWfCJ)

💬 Interested in partnering with Pharmidex? Connect with Radhakrishnan at the event or reach out to us!

#GeneTherapy #Pharmidex #DrugDiscovery #BiotechInnovation #Collaboration


February 4, 2026
At Pharmidex , we deliver high-quality LC-MS bioanalysis to support drug development across a wide range of analysis. Our experienced team supports preclinical, translational and clinical studies, providing accurate, reliable data under GLP and GCP to help drive confident decision-making. Learn more about our LC-MS capabilities: https://www.pharmidex.com/Discovery-Bioanalysis
February 2, 2026
Pharmidex offers high-quality Clinical Chemistry services delivering accurate, reliable data to support drug development. Our expert team and robust, quality-driven workflows enable trusted results that help accelerate decision-making and strengthen collaboration with pharma companies, CROs and academic partners. By working together, we support better science and more efficient drug development. 👉 Learn more: https://www.pharmidex.com/Clinical-chemistry
January 29, 2026
Pharmidex is delighted to share that Ash Alavijeh , Head of Operations, will be attending the UK BioIndustry Association (BIA) Annual Gala Dinner at the Roundhouse, London. Ash is looking forward to connecting with pharma and biotech colleagues to explore new collaborations, partnerships, and opportunities, all with the shared goal of advancing drug discovery and development. If you’re attending, feel free to connect with Ash this evening.
More Posts